Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shoulder pain in stroke survivors linked to worse balance and strength

NCT ID NCT06793852

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how shoulder pain impacts joint awareness, balance, touch sensation, and muscle strength in people who have had a stroke and have lasting weakness on one side (hemiplegia). Researchers measured these factors in 78 participants to better understand the effects of shoulder pain. The goal is to help improve treatment approaches for post-stroke shoulder pain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

78 people

The number who actually took part.

Started

Feb 2025

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of individuals diagnosed with stroke and receiving treatment at the Special Safranbolu Special Education and Rehabilitation Center in Karabük province. Based on previous similar studies, the sample size was calculated using power analysis with 80% power and a significance level of α=0.05, resulting in 78 participants.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * At least 3 months post-stroke, diagnosis of hemiplegia after stroke, aged 18 or older, having cognitive abilities and cooperation required to fulfill the study requirements, and willingness to participate in the study. Exclusion Criteria: * cognitive impairment interfering with informed consent or adherence to study assessments, aphasia, the presence of major neurological or rheumatological diseases affecting the musculoskeletal system other than stroke, and a history of surgery on the affected shoulder prior to stroke.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemiplegia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Karabük University

    Karabük, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.